Back to Results

Pre-IVF treatment with a GnRH antagonist in women with endometriosis - A prospective double-blind placebo-controlled trial JHM IRB

Study category: Infant Care

Is this Study for You?

Let's Get Started!

Description

To investigate the use of Orilissa to treat endometriosis prior to in-vitro fertilization procedures.

Details
Age

Adult

Eligibility

Ages: 18-38 years old Must have diagnosis of endometriosis Must be planning IVF for treatment of infertility

Type of Study

Treatment

Location

Outpatient CTRC

Principal Investigator
Nanette Santoro,  MD

Nanette Santoro, MD

Study ID

Protocol Number: 19-3115

More information available at ClinicalTrials.gov: NCT04173169

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers